Pfizer: US FDA, EU EMA approvals on coronavirus vaccine expected this month as well
|The US Food and Drug Administration (FDA) and EU’s European Medicines Agency (EMA) decisions on the coronavirus vaccines authorization expected this month as well, Pfizer Inc said in a briefing on Wednesday.
The statement from the American pharma giant came after the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA), a medical regulator, authorized the emergency-use supply for its covid vaccine.
Market implications
The optimism over vaccine-driven faster economic turnaround benefited global stocks last month. Although the above piece of news appears to have no impact on the risk sentiment, at the moment, with the S&P 500 futures still in the red above 3,650.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.